PB Fintech Limited

BSE:543390 Stock Report

Market Cap: ₹857.2b

PB Fintech Valuation

Is 543390 undervalued compared to its fair value, analyst forecasts and its price relative to the market?

Valuation Score

0/6

Valuation Score 0/6

  • Below Fair Value

  • Significantly Below Fair Value

  • Price-To-Sales vs Peers

  • Price-To-Sales vs Industry

  • Price-To-Sales vs Fair Ratio

  • Analyst Forecast

Share Price vs Fair Value

What is the Fair Price of 543390 when looking at its future cash flows? For this estimate we use a Discounted Cash Flow model.

Below Fair Value: 543390 (₹1881.35) is trading above our estimate of fair value (₹126.94)

Significantly Below Fair Value: 543390 is trading above our estimate of fair value.

Key Valuation Metric

Which metric is best to use when looking at relative valuation for 543390?

Key metric: As 543390 is barely profitable we use its Price-To-Sales Ratio for relative valuation analysis.

The above table shows the Price to Sales ratio for 543390. This is calculated by dividing 543390's market cap by their current revenue.
What is 543390's PS Ratio?
PS Ratio20.7x
Sales₹41.38b
Market Cap₹857.23b

Price to Sales Ratio vs Peers

How does 543390's PS Ratio compare to its peers?

The above table shows the PS ratio for 543390 vs its peers. Here we also display the market cap and forecasted growth for additional consideration.
CompanyForward PSEstimated GrowthMarket Cap
Peer Average2.4x
ICICIGI ICICI Lombard General Insurance
4.2x13.7%₹926.3b
ICICIPRULI ICICI Prudential Life Insurance
1x2.4%₹999.6b
SBILIFE SBI Life Insurance
1x6.0%₹1.4t
GODIGIT Go Digit General Insurance
3.5x17.9%₹308.7b
543390 PB Fintech
20.7x21.8%₹857.2b

Price-To-Sales vs Peers: 543390 is expensive based on its Price-To-Sales Ratio (20.7x) compared to the peer average (2.4x).

Price to Sales Ratio vs Industry

How does 543390's PS Ratio compare vs other companies in the Asian Insurance Industry?

21 CompaniesPrice / SalesEstimated GrowthMarket Cap
543390 20.7xIndustry Avg. 0.9xNo. of Companies49PS00.81.62.43.24+
21 CompaniesEstimated GrowthMarket Cap
No more companies

Price-To-Sales vs Industry: 543390 is expensive based on its Price-To-Sales Ratio (20.7x) compared to the Asian Insurance industry average (0.9x).

Price to Sales Ratio vs Fair Ratio

What is 543390's PS Ratio compared to its Fair PS Ratio? This is the expected PS Ratio taking into account the company's forecast earnings growth, profit margins and other risk factors.

543390 PS Ratio vs Fair Ratio.
Fair Ratio
Current PS Ratio20.7x
Fair PS Ratio3.5x

Price-To-Sales vs Fair Ratio: 543390 is expensive based on its Price-To-Sales Ratio (20.7x) compared to the estimated Fair Price-To-Sales Ratio (3.5x).

Analyst Price Targets

What is the analyst 12-month forecast and do we have any statistical confidence in the consensus price target?

The above table shows the analyst 543390 forecast and predictions for the stock price in 12 month’s time.
DateShare PriceAverage 1Y Price TargetDispersionHighLow1Y Actual priceAnalysts
Current₹1,881.35
₹1,647.05
-12.5%
14.8%₹2,000.00₹1,220.00n/a19
Nov ’25₹1,705.10
₹1,549.89
-9.1%
16.4%₹1,975.00₹1,205.00n/a19
Oct ’25₹1,729.65
₹1,535.16
-11.2%
15.5%₹1,975.00₹1,205.00n/a19
Sep ’25₹1,768.85
₹1,489.06
-15.8%
14.4%₹1,855.00₹1,205.00n/a18
Aug ’25₹1,442.10
₹1,332.00
-7.6%
14.1%₹1,720.00₹1,070.00n/a18
Jul ’25₹1,517.20
₹1,290.65
-14.9%
12.6%₹1,600.00₹1,020.00n/a17
Jun ’25₹1,295.80
₹1,280.94
-1.1%
11.5%₹1,515.00₹1,020.00n/a17
May ’25₹1,265.65
₹1,004.24
-20.7%
18.9%₹1,340.00₹610.00n/a17
Apr ’25₹1,172.20
₹983.94
-16.1%
17.4%₹1,330.00₹610.00n/a17
Mar ’25₹1,116.65
₹966.82
-13.4%
15.4%₹1,150.00₹610.00n/a17
Feb ’25₹996.90
₹952.56
-4.4%
15.3%₹1,150.00₹610.00n/a16
Jan ’25₹800.55
₹871.69
+8.9%
15.5%₹1,100.00₹560.00n/a16
Dec ’24₹862.50
₹859.81
-0.3%
16.9%₹1,100.00₹560.00n/a16
Nov ’24₹701.85
₹828.27
+18.0%
15.6%₹1,000.00₹560.00₹1,705.1015
Oct ’24₹765.40
₹828.27
+8.2%
15.6%₹1,000.00₹560.00₹1,729.6515
Sep ’24₹769.70
₹837.43
+8.8%
15.4%₹1,000.00₹560.00₹1,768.8514
Aug ’24₹764.10
₹774.62
+1.4%
16.4%₹1,000.00₹595.00₹1,442.1013
Jul ’24₹697.20
₹751.67
+7.8%
14.6%₹980.00₹595.00₹1,517.2012
Jun ’24₹598.55
₹751.67
+25.6%
14.6%₹980.00₹595.00₹1,295.8012
May ’24₹600.40
₹719.58
+19.9%
16.8%₹950.00₹550.00₹1,265.6512
Apr ’24₹638.85
₹719.58
+12.6%
16.8%₹950.00₹550.00₹1,172.2012
Mar ’24₹574.45
₹706.67
+23.0%
16.8%₹950.00₹550.00₹1,116.6512
Feb ’24₹402.10
₹675.83
+68.1%
18.4%₹910.00₹550.00₹996.9012
Jan ’24₹447.55
₹680.42
+52.0%
17.8%₹910.00₹550.00₹800.5512
Dec ’23₹461.55
₹692.27
+50.0%
17.3%₹910.00₹550.00₹862.5011
Nov ’23₹391.90
₹743.70
+89.8%
16.8%₹1,020.00₹620.00₹701.8510

Analyst Forecast: Target price is lower than the current share price.

Discover undervalued companies

General Insurance Corporation of India

₹697.6b

Provides reinsurance services in India and internationally.

GICRE

₹397.65

7D

8.5%

1Y

24.4%

Star Health and Allied Insurance

₹272.3b

Provides health insurance products in India.

STARHEALTH

₹463.45

7D

1.2%

1Y

-19.8%

General Insurance Corporation of India

₹697.6b

Provides reinsurance services in India and internationally.

540755

₹397.15

7D

8.5%

1Y

24.4%